@xconomy.com 1 month ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com 2 months ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com 4 months ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com 5 months ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com 5 months ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com 5 months ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com 5 months ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com 6 months ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com 6 months ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@ENERGY 9 months ago
.@argonne becomes newest member of the Accelerating Therapeutics for Opportunities in Medicine, or #ATOM, in hopes of using #AI & #MachineLearning to revolutionize the current drug discovery process into a faster, more patient oriented model. ➡️ https://bit.ly/2oe8itL https://t.co/FYHejhI5pn
@xconomy.com 9 months ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com 10 months ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@techcrunch.com 1 year ago
Risks and rewards of digital therapeutics in treating mental disorders
@techcrunch.com 1 year ago
Neurobehavioral health company Blackthorn pulls in $76 million from GV to treat mental disorders
@geekwire.com 1 year ago
Seattle startup Rodeo Therapeutics raises more cash for regenerative medicine treatments
@xconomy.com 1 year ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
@xconomy.com 1 year ago
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit
@techcrunch.com 1 year ago
Aiming to change the way people take medicine, Lyndra Therapeutics raises $55 million
@xconomy.com 1 year ago
Former Zavante Executive Tapped as Abide Therapeutics President
@xconomy.com 1 year ago
Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges
@NeuroscienceNew 1 year ago
Hacking the Aging Code https://neurosciencenews.com/big-data-aging-10255/ Study describes a strategy for systematic development of novel anti-aging therapeutics and biomarkers of aging using the data from medical studies and large biobanks. #aging #bigdata #neuroscience #science
@xconomy.com 1 year ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
@xconomy.com 1 year ago
Delivery Robots in Big D, Rodriguez Leaves the Station, & More TX Tech
@xconomy.com 1 year ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com 1 year ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com 1 year ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@techcrunch.com 1 year ago
CB Therapeutics’ lab-grown cannabinoids could unlock new medicines and make others affordable
@xconomy.com 1 year ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
@xconomy.com 2 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
@xconomy.com 2 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M
@xconomy.com 2 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed
@venturebeat.com 2 years ago
Relay Therapeutics Secures $63 Million in Series B Financing
@theverge.com 3 years ago
Shell shock: why is a startup charging parents $180 for $2 worth of peanut butter?
@venturebeat.com 4 years ago
Solace Therapeutics Completes Enrollment of the SUCCESS Clinical Trial for the Vesair® Bladder Control System for Stress Urinary Incontinence
@thenextweb.com 5 years ago
You could soon be taking a robot pill that delivers drugs with sugar needles